Yoshiyuki Onda

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2022, Therapeutic advances in hematology.

Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis

K. Ohta, J. Kanda, M. Hino, 2021, European journal of haematology.

Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patients

J. Kanda, A. Takaori-Kondo, H. Haga, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide

K. Ohta, J. Kanda, T. Matsui, 2022, Therapeutic advances in hematology.

Surfactants Derived from Secondary Alcohols

Yoshiyuki Onda, Kenji Rakutani, Toru Inaoka, 1999 .

Immune-Mediated Hematopoietic Failure after Allogeneic Hematopoietic Stem Cell Transplantation: A Common Cause of Late Graft Failure in Patients with Complete Donor Chimerism.

S. Ogawa, K. Hosomichi, Naoko Sato, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors

S. Fujiwara, K. Sakamoto, K. Kawamura, 2020, Bone Marrow Transplantation.

Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry

K. Ohta, J. Kanda, M. Hino, 2020, International Journal of Hematology.

Dipeptidyl‐peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosis

Shizuka Kaneko, N. Anzai, S. Sakamoto, 2021, EJHaem.

Possible nosocomial transmission of virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

J. Kanda, M. Nagao, A. Takaori-Kondo, 2021, Annals of Hematology.

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum

K. Ohta, J. Kuroda, I. Matsumura, 2023, Leukemia research reports.